Resistance to Rocuronium in a Child with Schwartz-Jampel Syndrome Type 1 B

Abstract

In Schwartz-Jampel syndrome micrognathia and jaw muscle rigidity may result in difficult or impossible tracheal intubation. Since the dose-response relationship to muscle relaxants is unknown in this rare disease we assessed by mechanomyography the neuromuscular response to the rocuronium in a two-year-old child with Schwartz-Jampel syndrome (SJS) Type 1 B. Rocuronium's dose-response curve was markedly shifted (3.5-fold dose) to the right when compared to healthy children and intubation conditions were improved. This resistance to NDMR may result from a lower acetylcholine degradation rate suggested as being the consequence of mutation of the gene encoding perlecan (HSPG2) in SJS. Thus, considerably higher doses of NDMR than usual may be required for facilitation of tracheal intubation in patients with SJS. Since evidence for genetic heterogeneity of SJS exists we also recommend incremental doses of a rapidly acting NDMR with continuous monitoring of neuromuscular function so as to assess the optimum relaxant dose.

Key words

Dose-response Relationship - Muscle Relaxants - Perlecan - Acetylcholinesterase

References

• 1 Brown K A, Al-Gazali L I, Moynihan L M, Lench N J, Markham A F. et al . Genetic heterogeneity in Schwartz-Jampel syndrome: two families with neonatal Schwartz-Jampel syndrome do not map to human chromosome 1 p34-p36. 1.  J Med Genet. 1997;  34 685-687
• 2 Cadilhac J, Baldet P, Greze J, Duday H. E. M. G. Studies of two family cases of the Schwartz-Jampel syndrome.  Electrom Clin Neurophysiol. 1975;  15 5-12
• 3 Christova L G, Alexandrov A S, Ishpektova B A. Single motor unit pattern with Schwartz-Jampel syndrome.  J Neurol Neurosurg Psych. 1999;  66 252-253
• 4 Donlon J V, Ali H H, Savarese J J. A new approach to the study of four nondepolarizing relaxants in man.  Anesth Analg. 1974;  53 934-939
• 5 Eikermann M, Peters J. Probability of acceptable intubation conditions with low dose rocuronium during light sevoflurane anaesthesia in children.  Acta Anaesth Scand. 2001;  45 1036-1041
• 6 Fisher D M, Fahey M R, Cronelly R, Miller R D. Potency determination for vecuronium (Org NC 45): Comparison of cumulative and single-dose techniques.  Anesthesiology. 1982;  57 309-312
• 7 Goehlich-Ratmann G, Cohn R D, Baethmann M, Schaper J, Gillesen-Kaesbach G, Voit T. Arthrogryposis multiplex congenita in Schwartz-Jampel chondrodystrophic myotonia.  Brain and Development. 1998;  20 385
• 8 Nicole S, Ben Hamida C, Beighton P, Bakouri S, Belal S. Localization of the Schwartz-Jampel syndrome (SJS) locus to chromosome 1 p34-p36. 1 by homozygosity mapping.  Hum Mol Genet. 1995;  4 1633-1636
• 9 Nicole S, Davoine C S, Topaloglu H, Cattolico L, Barral D. et al . Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia).  Nat Gen. 2000;  26 480-483
• 10 Peng H B, Xie H, Rossi S G, Rotundo R L. Acetylcholinesterae clustering at the neuromuscular junction involves perlecan and dystroglycan.  J Cell Biol. 1999;  145 911-921
• 11 Ray S, Rubin A P. Anaesthesia in a child with Schwartz-Jampel syndrome.  Anaesthesia. 1994;  49 600-602
• 12 Taivainen T, Meretoja O A, Erkola O, Rautoma P, Juvakovski M. Rocuronium in infants, children, and adults during balanced anaesthesia.  Paediatr Anaesth. 1996;  6 271-275
• 13 Taylor R G, Layzer R B, Davis H S, Fowler W M. Continuous muscle fibre activity in the Schwartz-Jampel syndrome.  Electroencephalogr Clin Neurophys. 1972;  33 497-509
• 14 Theroux M C, Kettrick R G, Khine H H. Laryngeal mask airway and fiberoptic endoscopy in an infant with Schwartz-Jampel syndrome.  Anesthesiology. 1995;  82 605
• 15 Whalley D G, Ebrahim Z. Influence of carbamazepine on the dose-response relationship of vecuronium.  Br J Anaesth. 1994;  72 125-126